Radisens has a business to business commercial approach with the aim to develop strategic partnerships. These include technology licensing, development, manufacture and supply relationships with collaborators for chronic disease monitoring, companion diagnostics or related markets. In addition, the Gemini™ platform is expandable for the measurement of analytes other than those developed to date by Radisens.

Talk to us now

We welcome approaches from diagnostics and pharmaceutical organisations that seek to enhance their competitive edge or expand into disease monitoring or related markets where a fully quantitative, rapid diagnostic tool with instant off-the-shelf use is needed.

For controlled access to our data room, please sign-in below:

Forgot your password?